NOVARTINDPharmaceuticals
Novartis India Ltd — Balance Sheet
₹672.25
+0.00%
Novartis India Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.47 Cr | 2.47 Cr | 2.47 Cr | 2.47 Cr | — |
| Share Issued | 2.47 Cr | 2.47 Cr | 2.47 Cr | 2.47 Cr | — |
| Total Debt | 5.06 Cr | 6.97 Cr | 21.51 Cr | 24.01 Cr | — |
| Tangible Book Value | 784.96 Cr | 744.82 Cr | 775.66 Cr | 691.70 Cr | — |
| Invested Capital | 784.96 Cr | 744.84 Cr | 775.66 Cr | 691.70 Cr | — |
| Working Capital | 603.77 Cr | 542.06 Cr | 517.84 Cr | 492.31 Cr | — |
| Net Tangible Assets | 784.96 Cr | 744.82 Cr | 775.66 Cr | 691.70 Cr | — |
| Capital Lease Obligations | 5.06 Cr | 6.95 Cr | 21.51 Cr | 24.01 Cr | — |
| Common Stock Equity | 784.96 Cr | 744.82 Cr | 775.66 Cr | 691.70 Cr | — |
| Total Capitalization | 784.96 Cr | 744.82 Cr | 775.66 Cr | 691.70 Cr | — |
| Total Equity Gross Minority Interest | 784.96 Cr | 744.82 Cr | 775.66 Cr | 691.70 Cr | — |
| Stockholders Equity | 784.96 Cr | 744.82 Cr | 775.66 Cr | 691.70 Cr | — |
| Other Equity Interest | 772.62 Cr | 732.48 Cr | -0.04 Cr | -2.22 Cr | — |
| Retained Earnings | 768.98 Cr | 728.84 Cr | 759.72 Cr | 677.94 Cr | — |
| Additional Paid In Capital | 3.64 Cr | 3.64 Cr | 3.64 Cr | 3.64 Cr | — |
| Capital Stock | 12.34 Cr | 12.34 Cr | 12.34 Cr | 12.34 Cr | — |
| Common Stock | 12.34 Cr | 12.34 Cr | 12.34 Cr | 12.34 Cr | — |
| Total Liabilities Net Minority Interest | 162.85 Cr | 180.11 Cr | 207.28 Cr | 265.87 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 20.80 Cr | 22.91 Cr | 47.79 Cr | 49.45 Cr | — |
| Long Term Debt And Capital Lease Obligation | 3.21 Cr | 5.07 Cr | 17.39 Cr | 18.27 Cr | — |
| Long Term Capital Lease Obligation | 3.21 Cr | 5.07 Cr | 17.39 Cr | 18.27 Cr | — |
| Long Term Provisions | 17.39 Cr | 17.62 Cr | 22.61 Cr | 29.85 Cr | — |
| Current Liabilities | 142.05 Cr | 157.20 Cr | 159.49 Cr | 216.42 Cr | — |
| Other Current Liabilities | 3.44 Cr | 5.04 Cr | 3.78 Cr | 9.47 Cr | — |
| Current Debt And Capital Lease Obligation | 1.85 Cr | 1.90 Cr | 4.12 Cr | 5.74 Cr | — |
| Current Capital Lease Obligation | 1.85 Cr | 1.88 Cr | 4.12 Cr | 5.74 Cr | — |
| Current Debt | 0.00 | 0.02 Cr | 0.00 | — | — |
| Pensionand Other Post Retirement Benefit Plans Current | 25.81 Cr | 32.16 Cr | 0.00 | 5.48 Cr | — |
| Current Provisions | 26.50 Cr | 22.41 Cr | 55.71 Cr | 90.62 Cr | — |
| Payables | 85.79 Cr | 90.92 Cr | 83.96 Cr | 83.15 Cr | — |
| Other Payable | 18.82 Cr | 20.07 Cr | 22.77 Cr | 9.61 Cr | — |
| Dividends Payable | 2.06 Cr | 1.78 Cr | 1.52 Cr | 1.34 Cr | — |
| Total Tax Payable | 13.44 Cr | 7.48 Cr | 6.08 Cr | 8.26 Cr | — |
| Accounts Payable | 51.47 Cr | 61.59 Cr | 59.67 Cr | 72.20 Cr | — |
| Total Assets | 947.81 Cr | 924.93 Cr | 982.94 Cr | 957.57 Cr | — |
| Total Non Current Assets | 201.99 Cr | 225.68 Cr | 305.61 Cr | 248.84 Cr | — |
| Other Non Current Assets | 65.66 Cr | 0.01 Cr | 89.10 Cr | 6.20 Cr | — |
| Non Current Prepaid Assets | 119.29 Cr | 133.29 Cr | 6.85 Cr | 6.84 Cr | — |
| Non Current Deferred Taxes Assets | 15.48 Cr | 15.37 Cr | 15.80 Cr | 27.18 Cr | — |
| Investmentin Financial Assets | 0.16 Cr | 0.26 Cr | 0.64 Cr | 0.82 Cr | — |
| Available For Sale Securities | 0.16 Cr | 0.26 Cr | 0.64 Cr | 0.82 Cr | — |
| Net PPE | 4.54 Cr | 6.94 Cr | 19.25 Cr | 23.65 Cr | — |
| Accumulated Depreciation | -2.82 Cr | -6.92 Cr | -7.60 Cr | -9.29 Cr | — |
| Gross PPE | 7.36 Cr | 13.86 Cr | 26.85 Cr | 32.94 Cr | — |
| Other Properties | 3.57 Cr | 5.29 Cr | 17.40 Cr | 20.17 Cr | — |
| Machinery Furniture Equipment | 0.00 | 4.51 Cr | 4.77 Cr | 8.05 Cr | — |
| Buildings And Improvements | 7.36 Cr | 9.35 Cr | 4.68 Cr | 4.72 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 745.82 Cr | 699.26 Cr | 677.33 Cr | 708.73 Cr | — |
| Other Current Assets | 15.60 Cr | 16.04 Cr | 12.72 Cr | 70.81 Cr | — |
| Restricted Cash | 2.06 Cr | 1.78 Cr | 1.52 Cr | 1.34 Cr | — |
| Prepaid Assets | 16.54 Cr | 16.70 Cr | 17.47 Cr | 76.46 Cr | — |
| Inventory | 41.11 Cr | 44.86 Cr | 54.72 Cr | 57.07 Cr | — |
| Finished Goods | 41.11 Cr | 44.86 Cr | 54.72 Cr | 57.07 Cr | — |
| Other Receivables | 8.90 Cr | 9.47 Cr | 13.00 Cr | 12.10 Cr | — |
| Accounts Receivable | 40.14 Cr | 41.47 Cr | 36.16 Cr | 44.56 Cr | — |
| Allowance For Doubtful Accounts Receivable | -2.33 Cr | -2.50 Cr | -2.33 Cr | -2.65 Cr | — |
| Gross Accounts Receivable | 42.47 Cr | 43.97 Cr | 38.49 Cr | 47.21 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 637.07 Cr | 584.98 Cr | 554.42 Cr | 516.29 Cr | — |
| Other Short Term Investments | 585.00 Cr | 540.00 Cr | 535.00 Cr | 357.94 Cr | — |
| Cash And Cash Equivalents | 52.07 Cr | 44.98 Cr | 19.42 Cr | 158.35 Cr | — |
| Cash Equivalents | 49.00 Cr | 40.00 Cr | 15.00 Cr | 155.00 Cr | — |
| Cash Financial | 3.07 Cr | 4.98 Cr | 4.42 Cr | 3.35 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | 17.62 Cr | 22.61 Cr | 29.85 Cr | 80.80 Cr |
| Current Deferred Taxes Liabilities | — | 7.48 Cr | 6.08 Cr | 8.26 Cr | 12.18 Cr |
| Assets Held For Sale Current | — | 0.00 | 0.04 Cr | 0.91 Cr | 0.91 Cr |
| Taxes Receivable | — | — | 0.72 Cr | 2.01 Cr | 2.71 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Novartis India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.